QI
ALXN

Qualcomm Inc’s Alexion Pharmaceuticals ALXN Stock Holding History

Qualcomm Inc’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-100
Closed -$17K – 172
2015
Q1 		$17K Hold
100
– – ﹤0.01% 145
2014
Q4 		$19K Hold
100
– – ﹤0.01% 166
2014
Q3 		$17K Hold
100
– – ﹤0.01% 167
2014
Q2 		$16K Sell
100
-20,400
-100% -$3.22M ﹤0.01% 193
2014
Q1 		$3.12M Hold
20,500
– – 0.16% 140
2013
Q4 		$2.73M Hold
20,500
– – 0.14% 148
2013
Q3 		$2.38M Buy
+20,500
New +$2.25M 0.11% 179

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Qualcomm Inc's ALXN Position: Q2 2015 in Review

Qualcomm Inc sold out of Alexion Pharmaceuticals (ALXN) in Q2 2015, closing a stake of 100 shares — an estimated $17K sold.

Qualcomm Inc first reported a position in ALXN in Q3 2013 and held it in 7 quarters. The position peaked at $3.12M in Q1 2014. 548 funds tracked by Wall St. Rank hold ALXN as of Q2 2015.

  • Qualcomm Inc reported no remaining Alexion Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Qualcomm Inc sold 100 Alexion Pharmaceuticals shares in Q2 2015, an estimated $17K.
  • Qualcomm Inc first reported a position in Alexion Pharmaceuticals in Q3 2013 and held it in 7 quarters.
  • Qualcomm Inc's Alexion Pharmaceuticals position peaked at $3.12M in Q1 2014.
  • 548 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2015.

Based on Qualcomm Inc's 13F filing for Q2 2015, filed 13 Aug 2015.